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Abstract
Background:  Mapping DNaseI hypersensitive sites is commonly used to identify regulatory
regions in the genome. However, currently available methods are either time consuming and
laborious, expensive or require large numbers of cells. We aimed to develop a quick and
straightforward method for the analysis of DNaseI hypersensitive sites that overcomes these
problems.
Results: We have developed a modified Multiplex Ligation-dependent Probe Amplification (MLPA)
approach for the identification and analysis of genomic regulatory regions. The utility of this
approach was demonstrated by simultaneously analysing 20 loci from the ENCODE project for
DNaseI hypersensitivity in a range of different cell lines. We were able to obtain reproducible
results with as little as 5 × 104 cells per DNaseI treatment. Our results broadly matched those
previously reported by the ENCODE project, and both technical and biological replicates showed
high correlations, indicating the sensitivity and reproducibility of this method.
Conclusion: This new method will considerably facilitate the identification and analysis of DNaseI
hypersensitive sites. Due to the multiplexing potential of MLPA (up to 50 loci can be examined) it
is possible to analyse dozens of DNaseI hypersensitive sites in a single reaction. Furthermore, the
high sensitivity of MLPA means that fewer than 105 cells per DNaseI treatment can be used,
allowing the discovery and analysis of tissue specific regulatory regions without the need for
pooling. This method is quick and easy and results can be obtained within 48 hours after harvesting
of cells or tissues. As no special equipment is required, this method can be applied by any
laboratory interested in the analysis of DNaseI hypersensitive regions.
Background
Open chromatin is a characteristic of genomic loci with
regulatory functions. These regions are preferentially
digested by DNaseI [1], and the identification of DNaseI
hypersensitive sites is frequently used to identify and ana-
lyse regulatory regions such as promoters, enhancers and
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silencers [2,3]. However, currently available methods
have significant limitations. A commonly used approach
involves Southern blotting, but this is time consuming,
usually requires radioactivity and is limited to short
stretches of DNA. Several PCR-based methods have been
described [4,5], but these do not readily allow multiplex-
ing. Recent reports of large scale analysis of DNaseI hyper-
sensitive sites have used either microarrays [6-9] or deep
sequencing [9,10]. Whilst valuable for genome wide anal-
ysis, the costs involved are a limiting factor for many
applications (such as comparing different developmental
stages or tissues). Another disadvantage of those methods
is that they usually require many millions of cells. For ex
vivo studies, this might require extensive pooling of tis-
sues, meaning that these methods are not suitable for all
applications.
Multiplex Ligation-dependent Probe Amplification
(MLPA) was originally developed to detect deletions and
duplications in genomic DNA [11], and has become pop-
ular in diagnostic settings for a range of disorders [12,13].
It has since been modified for several other applications as
well, including methylation analysis [14], mRNA expres-
sion analysis [15], identifying copy number variation in
normal populations [16,17], genotyping of mouse mod-
els [18,19] and measuring the efficiency of Cre-mediated
recombination in mouse models [20]. The principle
advantages of this method are the sensitivity and multi-
plexing potential. It can be used to analyse up to 50
genomic loci with as little as 20 ng genomic DNA in a sin-
gle reaction. Furthermore, the only equipment that is
required is a thermocycler and DNA sequencer, readily
available to most researchers.
We describe here a quick and straightforward protocol for
analysing DNaseI hypersensitive sites. This is demon-
strated by the analysis of 20 different loci in a single reac-
tion, based on data published by the ENCODE
consortium [21].
Results
Probe design
Figure 1 outlines the protocol used in this study. To exam-
ine the general feasibility of our approach, we designed 11
probes to cover randomly chosen DNaseI hypersensitive
sites in HeLa cells as published by the ENCODE consor-
tium [21]. In addition, nine probes were designed in
regions that showed no evidence of DNaseI hypersensitiv-
ity. To be able to cover larger genomic regions and to give
greater flexibility in probe design we employed the
recently developed extension MLPA [20]. All 20 probes
were combined in a single mix, and could be differenti-
ated from each other on the basis of length (the final
product length range was 94-207 bp).
Nuclei isolation and DNaseI treatment
We tested different methods for the isolation of nuclei,
with the Ne-Per Kit (Thermo Scientific) found to be most
suitable. Although intended for the isolation and separa-
tion of nuclear and cytoplasmic proteins, it proved to be
useful for the isolation of nuclei. Another obstacle to over-
come was the isolation of the genomic DNA. This
approach requires efficient recovery of very long as well as
very short fragments of genomic DNA. Unfortunately,
DNA obtained using the standard method for this task,
phenol-chloroform purification, is not suitable for use
with MLPA, as traces of phenol are known to interfere
with the enzymatic reactions. Instead we used the High-
Pure PCR Purification Kit (Roche), which, according to
the manufacturer, is suitable for the isolation of fragments
of up to 50 kb. As expected, in our experiments the recov-
ery of DNA from the untreated and therefore most intact
sample, was often least efficient, however, the quality and
quantity of the DNA was still sufficient for MLPA analysis.
Figure 2 shows a typical example of digested DNA
obtained after treating isolated nuclei with increasing
amounts of DNaseI and purification.
Analysis of DNaseI hypersensitive sites in HeLa cells
We next used the same probe mix to analyse the DNaseI
hypersensitivity of DNA within intact nuclei of HeLa cells.
Method overview Figure 1
Method overview. Schematic overview of the steps 
involved in DNaseI-MLPA, including approximate times 
required for each step when using four different cell prepara-
tions with three different DNaseI concentrations. Results can 
be obtained in less than 48 hours.BMC Genomics 2009, 10:412 http://www.biomedcentral.com/1471-2164/10/412
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Figure 3A shows typical peak patterns obtained using
nuclei aliquots digested with increasing amounts of DNa-
seI. Several peaks show significantly decreased peak
height with increased DNaseI concentration, while others
remain virtually unchanged. Nine of 11 probes targeting
previously described DNaseI hypersensitive sites in HeLa
cells show a clear decrease in normalized peak heights
(defined as < 75% of the equivalent peak in undigested
DNA), whereas all nine probes targeting non-sensitive
loci show no significant decrease (figure 3B). These results
were highly reproducible, with the technical and biologi-
cal replicates giving an r2 > 0.9.
We also tested the same probe mix on DNA directly iso-
lated from HeLa cells. As can be seen in Figure 3C, there
are no significant changes in normalized peak heights
with increasing DNaseI digestion. This was expected as
these DNA samples should have no chromatin structure,
and all cuts by DNaseI should therefore occur in a random
fashion.
Comparison of results using other cell lines
We then analysed the same 20 loci for DNaseI hypersen-
sitivity in other cell lines. For this comparison we used
HEK293, C28 and S97 cells. While the results for C28 cells
were very similar to those of HeLa cells (data not shown),
we could identify differences in sensitivity for several
probes in HEK293 and S97 cells. As shown in Figure 4,
some probes identifying hypersensitive sites in HeLa cells
stay unchanged in the other cell lines (probes S9 in
HEK293 cells, S6 in S97 cells) and two of the probes not
showing the expected sensitivity in HeLa cells (S3 and S4)
do show sensitivity in HEK293 cells.
Determining the minimum cell number
We also tried to determine the minimum cell number that
could be used with this approach. As we were able to
obtain robust results and sufficient DNA for several repli-
cates from aliquots containing nuclei from about 2.5 ×
105 cells, we estimated the lower limit of required cells to
be around 5 × 104 (theoretically ~300 ng DNA). To con-
firm this number, we used aliquots of 5 × 104 HeLa cells
and treated them as described above and compared the
results with those obtained from experiments using 2.5 ×
105 cells per aliquot. Figure 5 shows the comparison of
results from 5 × 104 and 2.5 × 105 cells (r2 = 0.97).
Discussion
We describe here a simple technique that allows the rapid
analysis of many DNaseI hypersensitive sites using little
starting material. For a proof of principle we chose loci
that had been analysed by both array analysis and deep
sequencing as part of the ENCODE project [21].
We used 20 probes in one reaction (11 sensitive, 9 non-
sensitive in HeLa cells according to ENCODE data). Nine
of 11 of the probes targeted to hypersensitive sites showed
the expected decrease in peak height for HeLa cells. The
fact that two sensitive sites did not show the expected
drop in peak heights is probably due to different growth
conditions, differences in passage numbers or to our
batch of HeLa cells being different from the one used in
the ENCODE study rather than to limitations of our
method. This is supported by the high correlation
observed for both technical and biological replicates (r2 >
0.9) and the fact that those two probes showed sensitivity
in HEK293 cells.
We also examined three other cell lines, in order to exam-
ine the cell line specificity of our experimental approach.
We could show clear differences in hypersensitivity for
some loci compared to HeLa cells. Again, the conclusion
that these are cell type-specific differences is supported by
the concordance of replicate experiments (r2 > 0.9).
To determine suitable DNaseI digestion conditions for
our method, a range of different DNaseI concentrations
and incubation conditions were tested. Incubating the
digestion reactions with the indicated DNaseI amounts at
room temperature for 20 minutes gave more reproducible
Example of DNaseI digest Figure 2
Example of DNaseI digest. Typical result of the analysis 
of DNaseI treated samples by agarose gel electrophoresis. 
The untreated sample and those digested with 0.5 and 2 units 
of DNaseI were used in subsequent experiments. L = DNA 
ladder.BMC Genomics 2009, 10:412 http://www.biomedcentral.com/1471-2164/10/412
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MLPA on DNA from HeLa cells Figure 3
MLPA on DNA from HeLa cells. A) Representative MLPA peak patterns obtained from nuclei isolated from HeLa cells and 
subsequent treatment with 0, 0.5 and 2 units of DNaseI. Red peaks represent size standards, blue peaks the signals from the 
probes after PCR amplification. Black numbers show probes designed to bind to non-sensitive regions, blue numbers to sensi-
tive regions for HeLa cells as published by the ENCODE consortium. B) Analysis of experiment shown in 3A. Data were 
obtained from two independent experiments and two technical replicates (n = 4). Results shown as mean ± SD. C) Analysis of 
data derived from DNaseI treatment of naked DNA isolated from HeLa cells. In this case DNaseI digestion was with either 
0.25 units or 1 unit DNaseI for 1 minute on ice, as this DNA was far more susceptible to degradation than DNA in intact 
nuclei. Probes are grouped into sensitive and non-sensitive, and then ordered according to their length. N: non-sensitive, S: 
sensitive for HeLa cells as published by the ENCODE consortium.BMC Genomics 2009, 10:412 http://www.biomedcentral.com/1471-2164/10/412
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results than, for example, using less DNaseI and incubat-
ing at 37°C or incubations on ice (data not shown). By
analysing the digested DNA on an agarose gel it was pos-
sible to identify the most appropriate conditions. Most of
our experiments were carried out using nuclei from 2.5 ×
105 cells per DNaseI digestion aliquot, providing suffi-
cient DNA for several technical replicates. However, in the
case of HeLa cells this number could be reduced to only 5
× 104 cells, still providing highly reproducible results as
shown by an r2 of 0.97 when comparing the results of the
experiments with both cell numbers. Furthermore, we
found that two different DNaseI concentrations and an
undigested control are sufficient to analyse hypersensitive
sites, which reduces the amount of total starting material
required to about 1.5 × 105 cells.
Although we have used 20 probes in this study, there is
the potential to significantly increase the degree of multi-
plexing. Reducing the interprobe spacing to 3 bp would
allow up to 40 loci to be examined. Indeed, by designing
probes that can be labelled with different fluorophores
[22,23] it would be possible to analyse > 100 loci in a sin-
gle reaction.
Conclusion
We describe here a rapid and accurate method for assaying
DNaseI hypersensitive sites. In contrast to genome-wide
approaches such as deep sequencing or microarray analy-
sis, we consider the primary strength of this approach to
be when < 100 genomic loci are being analysed. As all loci
are analysed in a single reaction, relatively little starting
material is required. We have shown that < 105 cells per
DNaseI treatment can be used, which will allow the study
of e.g. embryonic organ development without extensive
pooling. The protocol is straightforward and results can be
easily obtained from many samples within 48 hours.
Finally, using this method makes it possible to also detect
heterozygous and homozygous deletions and duplica-
tions of the examined regions, which is an artifact that is
known to occur in cultured cells.
Methods
Cell culture
HEK293 (human embryonic kidney cells), C28 (chondro-
genic cells), HeLa (cervical cancer cells) and S97 (dermal
fibroblasts) were grown in DMEM containing 10% FBS
and supplemented with L-glutamine in T-25 flasks and
incubated at 37°C containing 5% CO2 in a humidified
atmosphere.
Cell harvest and isolation of nuclei
After reaching 95-100% of confluence, cells were washed
with PBS and harvested using 1 ml of 0.025% Trypsin-
EDTA. After 5-10 min incubation at 37°C, cells were
washed with 2 ml of 10% FBS containing DMEM and
carefully resuspended in a 1.5 ml Eppendorf tube in cold
PBS and placed on ice. To limit changes in chromatin
structure during treatment, nuclei isolation was per-
formed using 2.5 × 105 to 106 cells as soon as possible.
For isolation of nuclei, the NE-PER Kit (Thermo Scientific)
was used with the following modifications. To prevent
nuclei from excessive clumping and releasing DNA, twice
the recommended volumes of the solutions were used
and resuspension of cells/nuclei was carried out by care-
fully pipetting up and down rather than vortexing. Cen-
trifugation steps were carried out at 250 × g at 4°C.
DNaseI treatment of nuclei
Isolated nuclei were washed in 500 μl cold DNaseI buffer
containing 2% glycerol and carefully resuspended in 75 μl
DNaseI buffer containing 2% glycerol. 25 μl aliquots of
the nuclei suspension were added to 2 ml Eppendorf
tubes containing one control without DNaseI and increas-
ing amounts (0.5 - 2 units) of DNaseI (Promega) in 50 μl
DNaseI buffer containing 2% glycerol. The solutions were
mixed by carefully flicking the tubes and incubated for 20
min at room temperature (23°C).
Isolation and purification of DNaseI treated genomic DNA
DNaseI treated nuclei were lysed by adding 250 μl of
nuclei lysis buffer (200 mM NaCl, 150 mM Tris HCl pH 8,
Differences in DNaseI sensitivity between the tested cell  lines Figure 4
Differences in DNaseI sensitivity between the tested 
cell lines. The majority of probes gave similar peak patterns 
in all tested cell lines, with the exceptions shown here. As 
can be seen on the left, the two regions not showing sensitiv-
ity in HeLa cells are sensitive in HEK293 cells. On the other 
hand, region S9 in HEK293 and S6 in S97 cells show no sign 
of sensitivity in contrast to HeLa cells.BMC Genomics 2009, 10:412 http://www.biomedcentral.com/1471-2164/10/412
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10 mM EDTA pH 8, 0.2% SDS) containing 50 μg of Pro-
teinase K and incubated for 45 min at 55°C. 20 μg of RNa-
seA (Sigma) was added and incubated for 30 min at 37°C.
The DNaseI treated DNA was isolated and purified using
the HighPure PCR Purification Kit (Roche) according to
the manufacturer's instructions. DNA was eluted with 50
μl elution buffer provided with the kit. Purified DNA was
checked for quality and degree of DNaseI digestion by
agarose gel electrophoresis. DNA concentrations were
measured using the NanoDrop.
MLPA and fragment analysis
The MLPA probe mix was created by combining each
MLPA oligonucleotide in table 1 to a final concentration
of 4 nM. The extension MLPA was performed essentially
as described [20]. 100-200 ng of DNaseI-treated DNA of
each sample was denatured at 98°C for 5 min, and
allowed to cool to room temperature. 1.5 μl MLPA buffer
(MRC-Holland, the Netherlands) and 1.5 μl MLPA probe
mix were added to each sample, denatured at 95°C for 1
min then hybridized overnight at 60°C. The following
morning a ligation and elongation step was carried out at
54°C by adding 3 μl ligase buffer A, 3 μl ligase buffer B, 1
μl Ligase-65 (all MRC Holland, the Netherlands), 2 mM
dNTPs, 1 U Stoffel Taq polymerase (Applied Biosystems)
and H2O to a final volume of 40 μl. After 15-20 min the
ligase was inactivated by heating to 95°C for 5 min. The
PCR reaction consisted of 5 μl of ligated mix added to 2 μl
SALSA PCR buffer, 1 μl SALSA enzyme buffer, 1 μl SALSA
PCR primer, 0.25 μl SALSA polymerase (all MRC-Hol-
land, the Netherlands) and 15.75 μl H2O. The PCR reac-
tion started with a 1 min denaturation step at 95°C,
followed by 35-38 cycles of amplification (each cycle con-
sisting of 95°C for 30 sec, 58°C for 30 sec, 72°C for 30
sec) and concluded with 20 min at 72°C.
Fragment analysis was performed on an ABI3130 capillary
sequencer. Peak data was extracted using GeneMarker
software (Soft Genetics) and exported to Excel (Microsoft)
for further analysis.
MLPA data analysis
Basic data analysis was performed as described [24]. Peak
data for the naked DNA experiment was normalised to the
average of all probes in the examined samples, with all
other reactions being normalized to all non-sensitive
probes. To assist in visualisation of the results, normalized
ratios of all untreated samples were set to 1.
Comparison of results obtained using different cell numbers Figure 5
Comparison of results obtained using different cell numbers. Correlation of results obtained from experiments with 5 
× 104 (n = 1) and 2.5 × 105 (n = 4) HeLa cells per DNaseI treatment aliquot.BMC Genomics 2009, 10:412 http://www.biomedcentral.com/1471-2164/10/412
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Table 1: Probe sets used in this study.
Name Probe1 Probe2 Genomic location Product size Gap size
N1 1AAGACAGAGTCAGCACCAAGC
AACCTG
GAGCGGCTGCTTCTTTCTCTCTT
GC2
chr2:234,440,746-234,440,797 94 -
N2 1GAGCAGCACTTAGTACACAGA
GGCCTCTG
CCAGGATTGCAGAAGGCTTGCAG
AGG2
chrX:153,258,524-153,258,587 106 9
N3 1GACCTTACTTTGATGAAGGCA
GTTCTGC
CATGGGTGCCACGGTTTGAATGT
ATC2
chr21:33,073,083-33,073,161 121 25
N4 1CCCAGTGACCTACAGTAGAAC
TTTTCTGTGTCC
GCTGTTCTCCGTGCCTATCACCT
GTTAAAGG2
chr2:234,444,778-234,444,867 132 26
N5 1CAAATAGTCGAGTGGTACCTG
TTCAGCC
GACAGAACTAGGAAACAAATACC
TCCTCATTCTATATGGC2
chr5:131,655,909-131,656,020 154 44
N6 1GACAGAAAATGCAGTCCAGTT
GGTACAAGC
CTCTCTCAGGGCTGCTTCATGAA
CTTAC2
chr21:33,778,023-33,778,144 164 64
N7 1GCTGTTCAGCATTGGTGTAAG
TTCTGATTCC
CTCCAGACACCTGAGCCAAGAGA
AAGATT2
chr21:33,068,576-33,068,705 172 70
N8 1CTAAGGTGGCCATGCTTCTCT
GGATTTGC
CAGCTCATCCCGCGTCGATTCCT
GGAAGTGTTATC2
chr5:131,660,201-131,660,338 180 74
N9 1GGAAAGAGCAGGAGAAAGGGA
ATCTTGG
GTCTCTTCAGCTTGTGGGAACAA
ACGAG2
chr7:27,143,394-27,143,543 192 94
S1 1GTTTTGTACTGTGGGAGTCTG
AGAGCGAG
GAGGTCCGAAAGCCGAATCACAG
TC2
chr19:59,386,440-59,386,493 96 -
S2 1AGCTAAAGACGTTAGGAAACA
GAGCAGGGTG
GTTGAACGGGAGTGCAGCACGGT
TGT2
chr19:59,396,645-59,396,701 99 -
S3 1CGACTGCGAATTACTGTTTAT
GAGGTGACTC
GCTGGTTCTATCGGTGGACAGTG
GGACATTC2
chr19:59,386,011-59,386,072 104 -
S4 1GGTACGGAAGGCAGAATCGTA
CCTG
CCTTACCAGGAAAACGGACAATC
TTCC2
chr21:33,785,757-33,785,822 106 14
S5 1GCCACAAACTCAAATAGGAGA
CTCCGC
CGGTTTTCTATTGGCTAGAGCGG
AGAAGC2
chr2:234,427,935-234,428,007 115 17
S6 1ATGGGGTACGACTTCGAATCA
CGTGC
CCTGATGACCTCTAGAGGTAAAC
TCGTGCAC2
chr7:27,149,886-27,149,967 124 25
S7 1AACCTAGTCCTCCCAGGTTAG
CACG
CAGCCAGCCAACGCCTCTTCTGA
TTG2
chr19:59,396,374-59,396,459 128 35
S8 1TGTGAGGGACCTTGTTACTGG
GCAG
CATCAGGAGGTGTACTGCCGTAC
CATA2
chr5:131,658,970-131,659,067 140 46
S9 1CCGAGAGTGGGAGCTACTCAT
TTTGAGG
CCCTTTAATTAAAGTCGCAGGCA
CCTAGG2
chrX:153,252,787-153,252,889 145 46
S10 1CTCTGACGTAGTGTGACCTTG
CTCATCC
CGAATTCAGCTCTGCTAGGACTG
TTGG2
chr5:131,657,322-131,657,462 183 86BMC Genomics 2009, 10:412 http://www.biomedcentral.com/1471-2164/10/412
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S11 1GCTCTTTGCATCGCTCTCTGT
CGG
CGTCTTCGCACTTACGCGGAGCG
GTAA2
chr21:33,066,198-33,066,362 207 114
1=GGGTTCCCTAAGGGTTGGA 2=TCTAGATTGGATCTTGCTGGC
N(n): non-sensitive, S(n): sensitive probes for HeLa cells according to data published by the ENCODE consortium. The genomic coordinates are 
from the human genome assembly of June 2006 (hg18).
Table 1: Probe sets used in this study. (Continued)